Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Detalles Bibliográficos
Autores principales: Prada, Patricia O., Ropelle, Eduardo R., Mourão, Rosa H., de Souza, Claudio T., Pauli, Jose R., Cintra, Dennys E., Schenka, André, Rocco, Silvana A., Rittner, Roberto, Franchini, Kleber G., Vassallo, José, Velloso, Lício A., Carvalheira, José B., Saad, Mario J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Statement of Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482084/
https://www.ncbi.nlm.nih.gov/pubmed/28450418
http://dx.doi.org/10.2337/db17-rt07a
_version_ 1783245514252222464
author Prada, Patricia O.
Ropelle, Eduardo R.
Mourão, Rosa H.
de Souza, Claudio T.
Pauli, Jose R.
Cintra, Dennys E.
Schenka, André
Rocco, Silvana A.
Rittner, Roberto
Franchini, Kleber G.
Vassallo, José
Velloso, Lício A.
Carvalheira, José B.
Saad, Mario J.A.
author_facet Prada, Patricia O.
Ropelle, Eduardo R.
Mourão, Rosa H.
de Souza, Claudio T.
Pauli, Jose R.
Cintra, Dennys E.
Schenka, André
Rocco, Silvana A.
Rittner, Roberto
Franchini, Kleber G.
Vassallo, José
Velloso, Lício A.
Carvalheira, José B.
Saad, Mario J.A.
author_sort Prada, Patricia O.
collection PubMed
description
format Online
Article
Text
id pubmed-5482084
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-54820842017-12-27 Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185 Prada, Patricia O. Ropelle, Eduardo R. Mourão, Rosa H. de Souza, Claudio T. Pauli, Jose R. Cintra, Dennys E. Schenka, André Rocco, Silvana A. Rittner, Roberto Franchini, Kleber G. Vassallo, José Velloso, Lício A. Carvalheira, José B. Saad, Mario J.A. Diabetes Statement of Retraction American Diabetes Association 2017-07 2017-04-27 /pmc/articles/PMC5482084/ /pubmed/28450418 http://dx.doi.org/10.2337/db17-rt07a Text en © 2017 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Statement of Retraction
Prada, Patricia O.
Ropelle, Eduardo R.
Mourão, Rosa H.
de Souza, Claudio T.
Pauli, Jose R.
Cintra, Dennys E.
Schenka, André
Rocco, Silvana A.
Rittner, Roberto
Franchini, Kleber G.
Vassallo, José
Velloso, Lício A.
Carvalheira, José B.
Saad, Mario J.A.
Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title_full Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title_fullStr Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title_full_unstemmed Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title_short Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185
title_sort statement of retraction. egfr tyrosine kinase inhibitor (pd153035) improves glucose tolerance and insulin action in high-fat diet–fed mice. diabetes 2009;58:2910–2919. doi: 10.2337/db08-0506. pmid: 19696185
topic Statement of Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482084/
https://www.ncbi.nlm.nih.gov/pubmed/28450418
http://dx.doi.org/10.2337/db17-rt07a
work_keys_str_mv AT pradapatriciao statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT ropelleeduardor statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT mouraorosah statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT desouzaclaudiot statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT paulijoser statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT cintradennyse statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT schenkaandre statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT roccosilvanaa statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT rittnerroberto statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT franchinikleberg statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT vassallojose statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT vellosolicioa statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT carvalheirajoseb statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185
AT saadmarioja statementofretractionegfrtyrosinekinaseinhibitorpd153035improvesglucosetoleranceandinsulinactioninhighfatdietfedmicediabetes20095829102919doi102337db080506pmid19696185

Ejemplares similares